What is the address of ANGEL MANUEL LOZANO CARDIOLOGY?

The registered office of ANGEL MANUEL LOZANO CARDIOLOGY is located at Steekspelstraat 15, 1190 Vorst.

Is ANGEL MANUEL LOZANO CARDIOLOGY still active?

Yes. According to the CBE (28 September 2026) ANGEL MANUEL LOZANO CARDIOLOGY is active, legal situation “Normale toestand”, started on 11 May 2009.

Is ANGEL MANUEL LOZANO CARDIOLOGY registered on Peppol?

No, ANGEL MANUEL LOZANO CARDIOLOGY is currently not registered on the Peppol network.

What is the enterprise number of ANGEL MANUEL LOZANO CARDIOLOGY?

The enterprise number of ANGEL MANUEL LOZANO CARDIOLOGY is BE0811651161.

When was ANGEL MANUEL LOZANO CARDIOLOGY founded?

ANGEL MANUEL LOZANO CARDIOLOGY was founded on 11 May 2009.

Who are the directors of ANGEL MANUEL LOZANO CARDIOLOGY?

According to the 2025 annual accounts, the directors of ANGEL MANUEL LOZANO CARDIOLOGY are: ANGEL MANUEL LOZANO GONZALEZ.

Is ANGEL MANUEL LOZANO CARDIOLOGY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 11 May 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ANGEL MANUEL LOZANO CARDIOLOGY make in 2025?

ANGEL MANUEL LOZANO CARDIOLOGY posted a profit after taxes of € 55,953 in financial year 2025.

What is the revenue of ANGEL MANUEL LOZANO CARDIOLOGY?

As a small company, ANGEL MANUEL LOZANO CARDIOLOGY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 115,883.

ANGEL MANUEL LOZANO CARDIOLOGY (Private Limited) - Vorst

Dossier ANGEL MANUEL LOZANO CARDIOLOGY, printed on 28 September 2026 from databakkes.be/en/0811651161/angel-manuel-lozano-cardiology. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

ANGEL MANUEL LOZANO CARDIOLOGY from Vorst, company number BE0811651161, closed financial year 2025 with a result of € 55,953 after tax. For that financial year ANGEL MANUEL LOZANO CARDIOLOGY recorded a gross margin of € 115,883 and equity of € 801,314. Compared with financial year 2024, the result moved from € 74,004 to € 55,953. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 18, 2026.

What it is worth Growing

€ 801,314

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 55,953

▼ 24% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,801

▲ 86% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 787,054.

People and assets in 2025

Vehicles and equipment

€ 1,415

▼ 52% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 185,837

▼ 15% vs 2024

€ 39,146 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 22,088

▲ 90% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 15,275

▼ 50% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 176,872 Gross margin 2022: € 176,872 First fiscal year in the series	€ 139,258 Gross margin 2023: € 139,258 ▼ 21% vs 2022 (€ 176,872) Unfavourable step	€ 155,037 Gross margin 2024: € 155,037 ▲ 11% vs 2023 (€ 139,258) Favourable step	€ 115,883 Gross margin 2025: € 115,883 ▼ 25% vs 2024 (€ 155,037) Unfavourable step	▼ 25%
Profit after taxes	€ 103,989 Profit after taxes 2022: € 103,989 First fiscal year in the series	€ 61,752 Profit after taxes 2023: € 61,752 ▼ 41% vs 2022 (€ 103,989) Unfavourable step	€ 74,004 Profit after taxes 2024: € 74,004 ▲ 20% vs 2023 (€ 61,752) Favourable step	€ 55,953 Profit after taxes 2025: € 55,953 ▼ 24% vs 2024 (€ 74,004) Unfavourable step	▼ 24%
Equity	€ 609,604 Equity 2022: € 609,604 First fiscal year in the series	€ 671,356 Equity 2023: € 671,356 ▲ 10% vs 2022 (€ 609,604) Favourable step	€ 745,360 Equity 2024: € 745,360 ▲ 11% vs 2023 (€ 671,356) Favourable step	€ 801,314 Equity 2025: € 801,314 ▲ 8% vs 2024 (€ 745,360) Favourable step	▲ 8%
Total debts	€ 418,456 Total debts 2022: € 418,456 First fiscal year in the series	€ 379,771 Total debts 2023: € 379,771 ▼ 9% vs 2022 (€ 418,456) Favourable step	€ 321,859 Total debts 2024: € 321,859 ▼ 15% vs 2023 (€ 379,771) Favourable step	€ 288,200 Total debts 2025: € 288,200 ▼ 10% vs 2024 (€ 321,859) Favourable step	▼ 10%
Cash	€ 28,043 Cash 2022: € 28,043 First fiscal year in the series	€ 16,650 Cash 2023: € 16,650 ▼ 41% vs 2022 (€ 28,043) Unfavourable step	€ 17,140 Cash 2024: € 17,140 ▲ 3% vs 2023 (€ 16,650) Favourable step	€ 31,801 Cash 2025: € 31,801 ▲ 86% vs 2024 (€ 17,140) Favourable step	▲ 86%
Land & buildings	€ 479,294 Land & buildings 2022: € 479,294 First fiscal year in the series	€ 468,161 Land & buildings 2023: € 468,161 ▼ 2% vs 2022 (€ 479,294) Unchanged	€ 457,028 Land & buildings 2024: € 457,028 ▼ 2% vs 2023 (€ 468,161) Unchanged	€ 445,896 Land & buildings 2025: € 445,896 ▼ 2% vs 2024 (€ 457,028) Unchanged	▼ 2%
Retained profit	€ 597,204 Retained profit 2022: € 597,204 First fiscal year in the series	€ 658,956 Retained profit 2023: € 658,956 ▲ 10% vs 2022 (€ 597,204) Favourable step	€ 731,100 Retained profit 2024: € 731,100 ▲ 11% vs 2023 (€ 658,956) Favourable step	€ 787,054 Retained profit 2025: € 787,054 ▲ 8% vs 2024 (€ 731,100) Favourable step	▲ 8%
Bank debt	€ 279,834 Bank debt 2022: € 279,834 First fiscal year in the series	€ 246,981 Bank debt 2023: € 246,981 ▼ 12% vs 2022 (€ 279,834) Favourable step	€ 219,418 Bank debt 2024: € 219,418 ▼ 11% vs 2023 (€ 246,981) Favourable step	€ 185,837 Bank debt 2025: € 185,837 ▼ 15% vs 2024 (€ 219,418) Favourable step	▼ 15%
Balance sheet total	€ 1,028,061 Balance sheet total 2022: € 1,028,061 First fiscal year in the series	€ 1,051,127 Balance sheet total 2023: € 1,051,127 ▲ 2% vs 2022 (€ 1,028,061) Unchanged	€ 1,067,219 Balance sheet total 2024: € 1,067,219 ▲ 2% vs 2023 (€ 1,051,127) Unchanged	€ 1,089,513 Balance sheet total 2025: € 1,089,513 ▲ 2% vs 2024 (€ 1,067,219) Unchanged	▲ 2%

Key figures of ANGEL MANUEL LOZANO CARDIOLOGY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to ANGEL MANUEL LOZANO CARDIOLOGY?

What happened at ANGEL MANUEL LOZANO CARDIOLOGY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 18, 2026 New annual accounts for financial year 2025: profit of € 55,953 (▼ 24% vs 2024). Source: NBB ↗
May 11, 2009 Start of the company according to the CBE. KBO

In short

From € 103,989 profit in 2022 to € 55,953 profit in 2025.

Paid € 110,250 in corporate taxes since 2022.

Best year ever: 2022, with € 103,989 profit.

Original PDFs at the National Bank ↗

A new publication or filing at ANGEL MANUEL LOZANO CARDIOLOGY? We notify you, reason included.

Follow ANGEL MANUEL LOZANO CARDIOLOGY

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

ANGEL MANUEL LOZANO GONZALEZ

ANGEL MANUEL LOZANO CARDIOLOGY

Cardio SARE

Behind ANGEL MANUEL LOZANO CARDIOLOGY is ANGEL MANUEL LOZANO GONZALEZ. ANGEL MANUEL LOZANO GONZALEZ is also behind Cardio SARE.

See the full network in the app

Directors

According to the 2025 annual accounts

ANGEL MANUEL LOZANO GONZALEZ

Manager

Also active at: Cardio SARE

Establishments

Establishment units

Physical locations of this company

Registered office

Steekspelstraat 15

1190 Vorst

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0811.651.161
VAT number: BE 0811.651.161
Registered office: Steekspelstraat 15, 1190 Vorst
Names & denominations: ANGEL MANUEL LOZANO CARDIOLOGY · AMLC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 11 May 2009
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗